Chronic Disease, Diabetes Mellitus, Type 2
Conditions
Keywords
Long term health problems, chronic disease
Brief summary
This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?
Detailed description
A national survey of participant outcomes is important for documenting how the CDSMP program is impacting people with chronic diseases and influencing health care outcomes. This study will help bridge the research to practice gap and further our knowledge about the outcomes of evidence?based programs that are widely disseminated. Investigators hope to learn the answers to the following questions for English and Spanish-speaking populations: 1. How does the CDSMP impact a person's general health? 2. Does the CDSMP increase the use of healthful behaviors? 3. Does the CDSMP impact health care utilization? 4. What are the characteristics of those who benefit from the CDSMP? 5. Can these benefits be maintained over 6 and 12 month periods? 6. For people with type 2 diabetes, and hemoglobin A1c be impacted by the CDSMP?
Interventions
BEHAVIORALChronic Disease Self-Management Workshop
6 week, small group self-management workshop
Sponsors
Stanford University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 18 or over * Has a chronic health condition * Attending a Chronic Disease Self-Management Workshop at a designated host site in the United states * Speaks English or Spanish * For blood test portion of study: have type 2 diabetes
Exclusion criteria
* Do not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Health Status (symptoms, activities limitations) | Baseline to 6 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Health behaviors (exercise, medical adherence) | baseline to 6 months | — |
| Change in health related quality of life | baseline to 6 months | — |
| Change in Metabolic control (HbA1c for type 2 diabetics) | baseline to 6 months | — |
| Change in Health Care Utilization | baseline to 6 months | MD, emergency, hospital times and total nights |
Countries
United States
Outcome results
None listed